Diet Education App for Inflammatory Bowel Disease

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Alberta

No Placebo Group

Trial Summary

What is the purpose of this trial?

The goal of this clinical trial is to learn if an app designed for diet education can help patients with inflammatory bowel disease (IBD) learn about healthy eating. The main question\[s\] it aims to answer are: * Is the app easy to use? * Is the app useful? Researchers will compare the diet app to see if it is better at teaching patients about a healthy diet than the standard information they may receive from their doctor. Participants will be asked to use the app for one month and answer surveys to see how easy the app is to use and if it leads to healthier eating.

Research Team

Eligibility Criteria

This trial is for patients with inflammatory bowel disease (IBD) who are interested in managing their diet through an educational app. The study seeks individuals willing to use the app for a month and provide feedback via surveys.

Inclusion Criteria

My condition is currently stable.

Not pregnant

Willing and able to comply with all required study procedures

Exclusion Criteria

Conditions requiring dietary restrictions (e.g. Celiac disease, kidney disease, diabetes, eosinophilic esophagitis)

I have a high output from my ostomy.

Pregnancy or breastfeeding

Treatment Details

Interventions

• MyIBDDiet app (Behavioural Intervention)

Trial Overview The MyIBDDiet app, designed to educate IBD patients on healthy eating habits, is being tested for ease of use and effectiveness compared to standard dietary advice from doctors.

Participant Groups

Group I: MyIBDDiet users Experimental Treatment 1 Intervention

This group will use the MyIBDDiet app for 60 days and compared with the standard of care group.

Group II: Standard of Care Active Control 1 Intervention

This group will not use the app for the first 30 days, then begin using it for the following 30 days.

Who Is Running the Clinical Trial?

University of Alberta

Lead Sponsor

Trials

957

Recruited

437,000+

Bill Flanagan

University of Alberta

Chief Executive Officer since 2020

LLB from University of Toronto, LLM from Columbia University

Dr. Verna Yiu

University of Alberta

Chief Medical Officer since 2012

MD from University of Alberta, Fellowship in Pediatric Nephrology at Harvard University